MEDPLAST MEDICAL, INC. REZUM; UNIT, ELECTROSURGICAL ENDOSCOPIC (WITH OR WITHOUT ACCESSORIES)
|
Back to Search Results |
|
Model Number D2201 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Muscle Spasm(s) (1966); Urinary Retention (2119)
|
Event Date 07/17/2019 |
Event Type
Injury
|
Event Description
|
The patient underwent the study procedure and was given a prostate block, epidural, anti-anxiety and pain medication.During procedure a total of 15 treatments were performed.No device observations or adverse events occurred during treatment.The same day post procedure, the patient experienced bladder spasms for which myrbetriq (dose unknown) was administered.The bladder spasm resolved 7 days post onset symptoms.At 7 days post the index procedure, the patient started experiencing urinary retention for which catherization was performed.The urinary retention resolved 20 days post onset symptom.The investigator assessment of the patient symptom of bladder spasms and urinary retention were assessed as definitely related to the procedure and not related to the device.The clinical end point committee (cec) adjudicated the patient bladder spasm and urinary retention as definite treatment related.The cec adjudicated the bladder spasm as possible device related and unlikely device related for the urinary retention.
|
|
Event Description
|
The patient underwent the study procedure and was given a prostate block, epidural, anti-anxiety and pain medication.During procedure a total of 15 treatments were performed.No device observations or adverse events occurred during treatment.The same day post procedure, the patient experienced bladder spasms for which myrbetriq (dose unknown) was administered.The bladder spasm resolved 7 days post onset symptoms.At 7 days post the index procedure, the patient started experiencing urinary retention for which craterization was performed.The urinary retention resolved 20 days post onset symptom.The investigator assessment of the patient symptom of bladder spasms and urinary retention were assessed as definitely related to the procedure and not related to the device.The clinical end point committee (cec) adjudicated the patient bladder spasm and urinary retention as definite treatment related.The cec adjudicated the bladder spasm as possible device related and unlikely device related for the urinary retention.
|
|
Manufacturer Narrative
|
The device history record (dhr) confirmed that the devices met all material, assembly and performance specifications.The device is not available for analysis.A review of the device ifu and operators manual was completed and did not reveal any evidence of device misuse, off-label use, or failure to follow instructions.The potential cause and controls for complaints related to clinical events were identified.Based on the information currently available an evaluation conclusion code of known inherent risk of the device was assigned to this investigation.
|
|
Search Alerts/Recalls
|
|
|